Correlation Between Center Laboratories and Handa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Center Laboratories and Handa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Center Laboratories and Handa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Center Laboratories and Handa Pharmaceuticals, you can compare the effects of market volatilities on Center Laboratories and Handa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Center Laboratories with a short position of Handa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Center Laboratories and Handa Pharmaceuticals.

Diversification Opportunities for Center Laboratories and Handa Pharmaceuticals

0.22

Correlation Coefficient

Center Laboratories  Handa Pharmaceuticals

Modest diversification

The 3 months correlation between Center and Handa is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Center Laboratories and Handa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Handa Pharmaceuticals and Center Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Center Laboratories are associated (or correlated) with Handa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Handa Pharmaceuticals has no effect on the direction of Center Laboratories i.e., Center Laboratories and Handa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Center Laboratories and Handa Pharmaceuticals

Assuming the 90 days trading horizon Center Laboratories is expected to under-perform the Handa Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Center Laboratories is 1.63 times less risky than Handa Pharmaceuticals. The stock trades about -0.33 of its potential returns per unit of risk. The Handa Pharmaceuticals is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  5,780  in Handa Pharmaceuticals on September 26, 2024 and sell it today you would earn a total of  510.00  from holding Handa Pharmaceuticals or generate 8.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Center Laboratories  vs.  Handa Pharmaceuticals

Center Laboratories

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Center Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Handa Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Handa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Center Laboratories and Handa Pharmaceuticals

The main advantage of trading using opposite Center Laboratories and Handa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Center Laboratories position performs unexpectedly, Handa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Handa Pharmaceuticals will offset losses from the drop in Handa Pharmaceuticals' long position.

The idea behind Center Laboratories and Handa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.